Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease

Published: May 07, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., May 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Thomas F. Schaible, Ph.D. has joined the Company as Project Leader, Inflammatory Bowel Disease. Dr. Schaible will lead Coronado's R&D efforts in advancing TSO (Trichuris suis ova or CNDO-201) in inflammatory bowel disease (IBD).

Help employers find you! Check out all the jobs and post your resume.

Back to news